Quotient Investors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Quotient Investors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,200	Closed	-$535K	–	194
2017 Q1	$535K	Sell	8,200 -39,275	-83%	-$2.31M	0.32%	100
2016 Q4	$2.62M	Buy	+47,475	New	+$2.61M	1.65%	6
2015 Q3	–	Sell	-77,600	Closed	-$2.82M	–	271
2015 Q2	$2.82M	Buy	+77,600	New	+$2.45M	0.38%	73

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Quotient Investors's PRAH Position: Q2 2017 in Review

Quotient Investors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 8,200 shares — an estimated $535K sold.

Quotient Investors first reported a position in PRAH in Q2 2015 and held it in 3 quarters. The position peaked at $2.82M in Q2 2015. 236 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

Quotient Investors reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
Quotient Investors sold 8,200 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $535K.
Quotient Investors first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 3 quarters.
Quotient Investors's PRA Health Sciences, Inc. position peaked at $2.82M in Q2 2015.
236 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Quotient Investors's 13F filing for Q2 2017, filed 20 Jul 2017.